Brondi Raffaello, Bannò Filippo, Bendinelli Sara, Castelli Christian, Mancina Antonio, Marinoni Mauro, Sartiano Daniele, Sernissi Francesca, Bongioanni Paolo
TeCip Institute, Scuola Superiore Sant'Anna (Pisa) - Italy.
Stud Health Technol Inform. 2013;191:100-4.
Poor adherence to drug therapies still represents an unsolved problem. In order to provide a useful solution to chronic patients of all ages--with particular attention to the elderly--who are subjected to complex therapeutic regimen, an innovative ICT solution, called Dr.Drin, has been designed and tested. The aim of the developed framework is to assist the patient during the therapy and to enable and support a bidirectional communication between all healthcare stakeholders (doctors, caregivers and family members) and the patient. During the screening phase, patients were interviewed to understand what are the common practices they usually adopt to remember when and how to take a drug. The solutions which they rely the most on are the list of drugs, writing on the packaging, and setting up alarms. Patients who complained about difficulties of adherence and who had a smartphone were subsequently recruited to test Dr.Drin over a three-months period. In the following, preliminary results from the first twelve patients are presented and analyzed to prove the effectiveness of Dr.Drin in supporting patients adherence to therapies.
对药物治疗的依从性差仍然是一个尚未解决的问题。为了给所有年龄段的慢性病患者——尤其是老年人——提供一个有用的解决方案，他们需要遵循复杂的治疗方案，一种名为Dr.Drin的创新信息通信技术解决方案已经被设计并测试。所开发框架的目的是在治疗期间协助患者，并实现和支持所有医疗利益相关者（医生、护理人员和家庭成员）与患者之间的双向沟通。在筛查阶段，对患者进行了访谈，以了解他们通常采用哪些常见做法来记住何时以及如何服药。他们最依赖的解决方案是药物清单、在包装上做标记以及设置闹钟。随后招募了抱怨依从性困难且拥有智能手机的患者，在三个月的时间里对Dr.Drin进行测试。以下展示并分析了前12名患者的初步结果，以证明Dr.Drin在支持患者坚持治疗方面的有效性。
